Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer
A. pluriseta extracts inhibited DU-145 cell growth without causing cellular toxicity, suggesting great potential for development as an anti-prostate cancer agent. However, further in vitro and in vivo experiments are recommended.
Authors
- Florence Ng’ong’a (ORCID: https://orcid.org/0000-0002-9953-1746)
- Innocent Oluwaseun Okpako (ORCID: https://orcid.org/0000-0002-4191-0380)
- Cleophas Kyama (ORCID: https://orcid.org/0000-0001-6459-1514)
- Sospeter Ngoci Njeru (ORCID: https://orcid.org/0000-0003-1154-0777)
Institutions
- Jomo Kenyatta University of Agriculture and Technology (KE)
- Kenya Medical Research Institute (KE)
- African Centre for Technology Studies (KE)
Publication Details
- Journal
- BMC Complementary Medicine and Therapies
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1186/s12906-024-04642-8
- Citations
- 9
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 3.25
Funders
- Jomo Kenyatta University of Agriculture and Technology
- African Union
- Kenya Medical Research Institute